Dasatinib (anhydrous) | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Dasatinib Anhydrous
US Exclusivities

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-1-m-2026-04-20

PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

Contact Supplier

Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

Contact Supplier

pharmacompass-2-m-2026-04-20

Dasatinib anhydrous

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 32 USDMF, 5 JDMF, 13 EU WC, 5 KDMF, 22 NDC API, 43 Listed Suppliers

69 API Suppliers
32 USDMF
5 JDMF
13 EU WC
5 KDMF
22 NDC API
43 Listed Suppliers

DEVELOPMENTS

57 Drugs in Development

57 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

619 FDF Dossiers, 61 FDA Orange Book, 278 Europe, 22 Canada, 196 Australia, 15 South Africa, 47 Listed Dossiers

619 FDF Dossiers
61 FDA Orange Book
278 Europe
22 Canada
196 Australia
15 South Africa
47 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 3 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 1 Finar, 5 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 19 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Coating Systems & Additives, 31 Fillers, Diluents & Binders, 18 Controlled & Modified Release, 16 Granulation, 14 Direct Compression, 14 Thickeners and Stabilizers, 13 Disintegrants & Superdisintegrants, 9 Co-Processed Excipients, 9 Lubricants & Glidants, 8 Topical, 6 Film Formers & Plasticizers, 5 Empty Capsules, 5 Solubilizers, 4 Vegetarian Capsules, 4 Taste Masking, 4 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 3 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents, 1 Parenteral

37 Coating Systems & Additives
31 Fillers, Diluents & Binders
18 Controlled & Modified Release
16 Granulation
14 Direct Compression
14 Thickeners and Stabilizers
13 Disintegrants & Superdisintegrants
9 Co-Processed Excipients
9 Lubricants & Glidants
8 Topical
6 Film Formers & Plasticizers
5 Empty Capsules
5 Solubilizers
4 Vegetarian Capsules
4 Taste Masking
4 Chewable & Orodispersible Aids
3 API Stability Enhancers
3 Emulsifying Agents
3 Rheology Modifiers
2 Coloring Agents
1 Parenteral

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 57 News #PharmaBuzz

1 Data Compilation #PharmaFlow
57 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Regulatory FDF Prices, 16 Annual Reports

1 US Medicaid Prescriptions
4 Regulatory FDF Prices
16 Annual Reports

MARKET PLACE

11 APIs, 7 FDF Dossiers

11 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

132 US Patents, 18 US Exclusivities, 18 Health Canada Patents

132 US Patents
18 US Exclusivities
18 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

18 All

01 12BRISTOL MYERS SQUIBB

02 6HANDA THERAP

filter Product Reset all filters

18 All

01 18DASATINIB

filter Exclusivity Expiration Date Reset all filters

18 All

01 62025-12-21

02 62026-06-21

03 62026-12-05

filter Exclusivity Code Reset all filters

18 All

01 6M-307

02 6ODE-225

03 6PED

Product Main Page

BRISTOL MYERS SQUIBB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DASATINIB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-225

Exclusivity Expiration Date

2025-12-21

Application Number

21986

Product Number

6

Exclusivity Details

01

BRISTOL MYERS SQUIBB

Bioprocess International Europe

Not Confirmed

BRISTOL MYERS SQUIBB

U.S.A

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-225

Exclusivity Expiration Date : 2025-12-21

Application Number : 21986

Product Number : 6

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL MYERS SQUIBB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DASATINIB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-225

Exclusivity Expiration Date

2025-12-21

Application Number

21986

Product Number

5

Exclusivity Details

02

BRISTOL MYERS SQUIBB

Bioprocess International Europe

Not Confirmed

BRISTOL MYERS SQUIBB

U.S.A

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-225

Exclusivity Expiration Date : 2025-12-21

Application Number : 21986

Product Number : 5

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL MYERS SQUIBB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DASATINIB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-225

Exclusivity Expiration Date

2025-12-21

Application Number

21986

Product Number

4

Exclusivity Details

03

BRISTOL MYERS SQUIBB

Bioprocess International Europe

Not Confirmed

BRISTOL MYERS SQUIBB

U.S.A

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-225

Exclusivity Expiration Date : 2025-12-21

Application Number : 21986

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL MYERS SQUIBB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DASATINIB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-225

Exclusivity Expiration Date

2025-12-21

Application Number

21986

Product Number

3

Exclusivity Details

04

BRISTOL MYERS SQUIBB

Bioprocess International Europe

Not Confirmed

BRISTOL MYERS SQUIBB

U.S.A

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-225

Exclusivity Expiration Date : 2025-12-21

Application Number : 21986

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL MYERS SQUIBB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DASATINIB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-225

Exclusivity Expiration Date

2025-12-21

Application Number

21986

Product Number

2

Exclusivity Details

05

BRISTOL MYERS SQUIBB

Bioprocess International Europe

Not Confirmed

BRISTOL MYERS SQUIBB

U.S.A

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-225

Exclusivity Expiration Date : 2025-12-21

Application Number : 21986

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HANDA THERAP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

DASATINIB

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

M-307

Exclusivity Expiration Date

2026-12-05

Application Number

216099

Product Number

4

Exclusivity Details

06

HANDA THERAP

Bioprocess International Europe

Not Confirmed

HANDA THERAP

Country

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-307

Exclusivity Expiration Date : 2026-12-05

Application Number : 216099

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

BRISTOL MYERS SQUIBB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DASATINIB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-225

Exclusivity Expiration Date

2025-12-21

Application Number

21986

Product Number

1

Exclusivity Details

07

BRISTOL MYERS SQUIBB

Bioprocess International Europe

Not Confirmed

BRISTOL MYERS SQUIBB

U.S.A

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-225

Exclusivity Expiration Date : 2025-12-21

Application Number : 21986

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HANDA THERAP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

DASATINIB

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

M-307

Exclusivity Expiration Date

2026-12-05

Application Number

216099

Product Number

3

Exclusivity Details

08

HANDA THERAP

Bioprocess International Europe

Not Confirmed

HANDA THERAP

Country

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-307

Exclusivity Expiration Date : 2026-12-05

Application Number : 216099

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

HANDA THERAP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

DASATINIB

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

M-307

Exclusivity Expiration Date

2026-12-05

Application Number

216099

Product Number

2

Exclusivity Details

09

HANDA THERAP

Bioprocess International Europe

Not Confirmed

HANDA THERAP

Country

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-307

Exclusivity Expiration Date : 2026-12-05

Application Number : 216099

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

HANDA THERAP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

DASATINIB

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

M-307

Exclusivity Expiration Date

2026-12-05

Application Number

216099

Product Number

1

Exclusivity Details

10

HANDA THERAP

Bioprocess International Europe

Not Confirmed

HANDA THERAP

Country

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-307

Exclusivity Expiration Date : 2026-12-05

Application Number : 216099

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.